Stable Isotopes Product Detail

Nepafenac-d5

Chemical Properties and Information

Product Code: CS-O-02982 Stable Isotopes
Nepafenac-d5
API Family
Nepafenac
Product Code
CS-O-02982

Nepafenac-d5

Nepafenac Stable Isotopes
Stock Status: In Stock
Live

CAT No.
CS-O-02982
CAS No.
1246814-53-8
Molecular Formula
C15H9D5N2O2
Molecular Weight
259.31
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
1246814-53-8
Product Code
CS-O-02982
M.F.
C15H9D5N2O2
M.W.
259.31
Smiles
C(=O)(C1=C(N)C(CC(N)=O)=CC=C1)C2=C(C(=C(C(=C2[2H])[2H])[2H])[2H])[2H]
Category
Stable Isotopes
API Family
Nepafenac
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
2-(2-Amino-3-benzoylphenyl)acetamide-D5
References
"Walsh; D,A,; et al,: J, Med, Chem,; 33; 2296 (1990); Gamache; D,A,; et al,: Inflammation; 24; 357 (2000); Lindstrom; R,; et al,: Curr, Med, Res, Opin,; 22; 397 (2006);"
Synonyms
2-[2-Amino-3-(2,3,4,5,6-pentadeuteriobenzoyl)phenyl]acetamide
Application Notes
Labelled Nepafenac . A non-steroidal anti-inflammatory with analgesic activity; selective COX-2 inhibitor. Prodrug of Amfenac. Intended for use as an internal standard for the quantification of Nepafenac by GC- or LC-mass spectrometry.
Purity by HPLC
98.07
Hazard Compound
Refer MSDS for accurate information.
Overview
Labelled Nepafenac . A non-steroidal anti-inflammatory with analgesic activity; selective COX-2 inhibitor. Prodrug of Amfenac. Intended for use as an internal standard for the quantification of Nepafenac by GC- or LC-mass spectrometry.
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.